US Patent 11352363 Spiropyrrolidine derived antiviral agents
Patent 11352363 was granted and assigned to Enanta Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11352363 Spiropyrrolidine derived antiviral agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.